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1  | INTRODUC TION
In the last decades, patient and public involvement (PPI) in health 
research has steadily grown worldwide.1 Various policy directives 
promoting PPI have been introduced, and funding bodies increas-
ingly require the integration of PPI into research projects.2,3 PPI is 
well established in North America, the UK and Australia through 
support organizations such as Patient- Centered Outcomes 
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Abstract
Background: Patient and public involvement (PPI) in health research is on the rise 
worldwide. Within cancer research, PPI ensures that the rapid development of medi-
cal and technological opportunities for diagnostics, treatment and care corresponds 
with the needs and priorities of people affected by cancer. An overview of the expe-
riences, outcomes and quality of recent PPI in cancer research would provide valua-
ble information for future research.
Objective: To describe the current state of PPI in cancer research focusing on the 
research stages, applied methods, stated purposes and outcomes, and challenges 
and recommendations.
Methods: A search was conducted on PubMed, CINAHL and PsycINFO for literature 
published	from	December	2006	to	April	2017.	Original	research	studies	describing	
the involvement of cancer patients, stakeholders and carers as active partners at any 
stage of the research process were included.
Results: Twenty- seven studies were included, the majority reporting PPI at the early 
stages of research, that is, during the definition and prioritization of research topics 
and the development of recruitment strategies. Few studies reported PPI at later 
stages and across the research process. Challenges and recommendations were only 
briefly described, and critical reflection on the PPI process was lacking.
Conclusion: PPI needs to be integrated more broadly in the cancer research process. 
The quality of reporting PPI should be strengthened through greater critical reflec-
tions including both positive and negative experiences of the PPI process. This will 
contribute to the further development of PPI and its potential in cancer research.
K E Y W O R D S
cancer research, patient and public involvement, systematic review
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Research	 Institute	 (PCORI)	 in	 the	 United	 States	 and	 INVOLVE	 in	
the UK, and through the dissemination of PPI models and scientific 
publications.1,4,5
Involving patients, carers, patient organizations and communi-
ties in the research process is valued for multiple reasons. First of 
all, PPI is related to democratic values as it empowers patients and 
citizens to influence the research agenda, a task traditionally led by 
clinicians, researchers and industry.4,6,7 The democratizing value of 
PPI is often described based on various degrees of involvement, in 
accordance	 with	 Arnstein’s	 1969	 ladder	 of	 citizen	 participation,8 
which ranges from non-participation to tokenistic involvement to de-
grees of citizen power.9 INVOLVE distinguishes between three PPI 
approaches: consultation, collaboration and user- led.10	 Similarly,	
Health Canada divides PPI into five stages: inform or educate, gather 
information, discuss, engage and partner.11
Aside from the democratizing value of PPI, it is also valued 
for potentially enhancing the quality of research. PPI can improve 
methodological quality, for example, by increasing recruitment and 
retention of study participants because patient/public representa-
tives have better access to the study population that they are part 
of, thereby ensuring study acceptability in the target population.12 
At an epistemological level, proponents of experience- based 
knowledge argue that patients and carers’ personal experiences 
of illness are important contributions to clinical research- based 
knowledge.3,5
Patient and public involvement methods and approaches cover 
a broad range of areas,10,12,13 such as conventional qualitative and 
quantitative research methods (eg, interviews, focus groups and 
surveys), which are applied either independently or combined. 
Furthermore, PPI also employs approaches and methods related 
to project management, where patient/public participants are con-
sulted, for example, in Delphi rounds or serve as representatives 
in steering committees and on expert panels that discuss research 
design, results and dissemination. PPI is also being practised using 
more comprehensive models, which include several steps and meth-
ods (scientific and non- scientific). The James Lind Alliance (JLA), for 
instance, is an independent organization funded by the National 
Institute for Health Research and the Medical Research Council in 
the UK and provides a platform for applying an integrative approach 
which brings patients, carers and health- care professionals together 
in	 Priority	 Setting	 Partnerships.	 The	 approach	 uses	 deliberative	
methods to identify uncertainties, interpret these as potential re-
search questions and compare these to the existing evidence before 
engaging in different methods for prioritization (eg, expert panels, 
surveys, focus groups). Often the final prioritization takes place at 
face- to face meetings with group discussions.7,14,15 PPI is also an 
integral aspect of participatory action research16 and community- 
based participatory research, each of which has its own set of meth-
odologies and approaches.17
The variety of values and methods associated with practising 
PPI make forming an overview and developing recommendations for 
best practice difficult. With PPI becoming increasingly common in 
research, the discussion continues regarding its purposes, outcomes 
and impact, not to mention who it benefits and what quality stan-
dards should be applied to evaluate PPI.18-21
1.1 | PPI in cancer research
Cancer affects a vast population of patients, survivors, relatives and 
carers. The growing prevalence, uncertain (life- threatening) progno-
sis and a high symptom burden make PPI relevant in cancer research 
to ensure that the rapid development of medical and technological 
opportunities for diagnostics, treatment and care is aligned with the 
needs and priorities of the growing population of people affected 
by	cancer.	Years	of	initiatives	in	the	UK	and	the	United	States	have	
made PPI a familiar aspect of cancer research, especially due to for-
mal training requirements and the presence of patient advocates/
representatives on review panels since the 1990s.5 Therefore, PPI in 
cancer research is a field particularly suitable to study and learn from 
in terms of how PPI is practised and which outcomes and impact PPI 
produces.
Earlier reviews in the field include a study by Hubbard et al5 that 
focused on PPI in cancer research, policy, planning and practice from 
1994 to 2004. In a later review of 52 research papers, evaluations 
and recommendations, Hubbard et al22 centred on PPI in research. 
They distinguished between involvement in scientific review panels 
and	participatory	research	projects	(n	=	7),	and	involvement	in	clin-
ical trials (n = 3). The review showed that PPI in cancer research has 
been	carried	out	primarily	in	the	United	States	and	the	UK,	reflecting	
a general PPI trend. Their results also highlighted that involvement 
was more prominent in women with breast cancer (n = 22 publica-
tions). Moreover, studies mainly reported the impact of PPI on re-
search designs, accrual and response rates. The authors concluded 
that the agenda of involvement in cancer research has taken root but 
that evaluation is needed to show the impact of involving patients in 
the research process.22 Because PPI in cancer research continues to 
grow, gaining an overview of the experiences, challenges, outcomes 
and quality of more recent PPI in cancer research is an important 
step in providing information and recommendations for future PPI 
in cancer research.
The aim of this review is to describe the current state of PPI in 
cancer research. Three central research questions will be explored: 
(a) At which stages of research does PPI take place and which meth-
ods are applied? (b) What are the stated purposes and outcomes of 
PPI? and (c) What are the stated challenges and recommendations 
of the PPI process? The findings from this review are discussed in 
terms of the democratic and research- oriented values of PPI in can-
cer research.
2  | METHODS
2.1 | Search strategy
A	 systematic	 approach	 based	 on	 the	 PRISMA	 guidelines	 was	 ap-
plied to report the results.23 Three databases were systematically 
searched: MEDLINE/PubMed, the Cumulative Index to Nursing and 
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Allied Health Literature (CINAHL) and PsycINFO. The strategy was 
customized for each database and included controlled vocabulary, 
for	example,	Medical	Subject	Headings	(MeSH	terms)	and	free-	text	
keywords to identify relevant studies for this review.
The search was conducted using the following keywords: Cancer, 
Hematol*, Oncolog*,AND Citizen driven, Community participation, 
Consumer involvement, Consumer participation, Engaging patients, 
Involving patients, Lay involvement, Lay participation, Partnership*, 
Partnership, Patient driven, Patient engagement, Patient involve-
ment, Patient participation, Patients view*, Public engagement, Public 
involvement,	Public	participation,	Stakeholder*,	Stakeholder	driven,	
User driven, User involvement, User participation, AND Research 
agenda*, Design, Priorities, Priority, Prioritization, Prioritizing, 
Process.
The full search strategy for each database is available upon re-
quest by contacting the corresponding author (KHP). The search was 
exported and managed in RefWorks, including identification of du-
plicates. The search was limited to the English language and included 
studies	published	from	December	2006	to	April	2017.
2.2 | Inclusion and exclusion criteria
This review included original research studies describing the involve-
ment of cancer patients, survivors and carers at any stage of the re-
search	process	with	a	clear	PPI	purpose	and	outcome.	Studies	that	
solely described user experiences with involvement in research were 
excluded if the purpose and outcomes of the PPI in the research pro-
cess were not described. Other exclusion criteria were studies that 
described PPI in service development, if no follow- up research was 
conducted, prevention and screening projects.
The first author (KHP) carried out a systematic search in 
December	2016	and	in	April	2017	in	cooperation	with	information	
specialists. After duplicates were removed, the search resulted in 
1297	hits	in	PubMed,	854	in	CINAHL	and	904	in	PsycINFO	(Figure	1).
KHP reviewed the titles and/or abstracts in the searches and ex-
cluded studies that did not match the inclusion criteria. Two research-
ers	(KHP	and	LS)	then	divided	the	remaining	abstracts	between	them	
and reviewed the abstracts excluded by the other researcher. If the 
researchers disagreed, the study was included for full- text assessment. 
F IGURE  1 PRISMA	flow	chart
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For the studies initially agreed upon, the researchers did a full- text read-
ing	and	assessment.	The	sorting	process	resulted	in	27	studies	whose	
validity	 was	 assessed	 with	 the	 Critical	 Appraisal	 Skills	 Programme	
(CASP)	checklist	 for	qualitative	studies	and	Mixed	Method	Appraisal	
Tool (MMAT) for mixed and quantitative studies.24 The quality assess-
ment was carried out to gain insight into the methodological quality of 
the articles but did not result in further exclusions.
2.3 | Data analysis
Data	analysis	was	conducted	by	KHP	and	LS	and	discussed	with	KP	and	
MJ in cases of discrepancy. Data regarding PPI methods were extracted 
according to Table 1, which was developed during the review process. 
Initially, the table indicated three overall stages: research development, 
conducting research and research dissemination inspired by similar ta-
bles.4,13 However, the three stages were further divided into ten sub-
categories to align with nuances in the included studies (Table 1).
Furthermore, the following data were extracted according to 
Table 2: publication year, study origin, population (cancer disease), 
methods applied, number of involved patients/carers, the stated pur-
pose of PPI, PPI outcomes, the stated challenges specifically related to 
PPI and the stated recommendations specifically related to PPI.
3  | RESULTS
Based	on	the	review’s	 inclusion	criteria,	27	articles	were	 included.	
Table 2 presents the findings subtracted from the articles. In the 
following, we describe the current PPI trends and characteristics in 
cancer research.
3.1 | Study characteristics: origin and population
The UK represents the majority of the publications (n = 12),6,25-35 fol-
lowed	by	the	United	States	(n	=	7)36-42 and Australia (n = 3).43-45 A sin-
gle	study	represents	several	countries	(Germany,	Iceland,	Italy,	Japan,	
Spain,	the	UK),46 and the remaining studies report findings from other 
countries:	Sweden,47 Denmark,48 the Netherlands49 and Canada.50
The populations in the studies were defined in various ways, 
though most were disease- specific, while other populations were 
defined according to age or ethnicity. The majority of the stud-
ies (n = 13) focused on specific cancer diseases: breast cancer 
(n = 4),36,37,47,50 including a study specifically focusing on breast can-
cer in a Latino population,36 followed by lung cancer (n = 4),30,32,38,41 
blood cancer (n = 2),43,49 colorectal cancer (n = 1),39 gynaecological 
cancer (n = 1)27 and bowel cancer (and other bowel diseases) (n = 1).35 
Some	studies	(n	=	8)	represented	heterogeneous	cancer	types	with	
no specific population/disease focus.6,26,29,31,40,42,44,45 Other studies 
(n = 8) also represented heterogeneous cancer types but had specific 
foci, for example, studies on young people (n = 3),33,34,48 palliation 
(n = 3)25,28,46 and a community with high cancer disparity (n = 1).42
3.2 | Research stages and applied PPI methods
Figure 2 shows the distribution of studies for each research stage. 
The majority of the studies (n = 20) reported PPI at a single stage in 
Research stage Subcategories Definition
1. Development of research 
focus
Research definition Definition of research themes/
questions
Research prioritization Prioritization of research 
themes/questions
2. Development of research 
design
Method development Development of research tools, 
for example, questionnaires, 
interview guides, patient- 
reported outcome 
measurements
Study	design	
development
Development of entire study 
designs
3. Recruitment Recruitment strategy Development of recruitment/
retention strategies for research 
projects
Recruitment Participation in recruiting 
research participants
4. Data generation Data generation Participation in data generation, 
for example, interviewing
5. Data processing Analysis Participation in data analysis
6.	Research	dissemination Dissemination Dissemination of research, for 
example, co- author/presenter
Dissemination strategy Development of dissemination 
strategies
TABLE  1 Research stages of patient 
and public involvement
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the	 research	 process.	 Some	 studies	 (n	=	5)	 involved	 patients	 at	 two	
stages (both the definition and prioritization of research questions/
themes).6,25,32,43,45 A few studies (n = 3) involved patients/the pub-
lic at various research stages.38,42,50 Because these studies reported 
PPI at several stages, the number of research stages (n = 41) in the 
figure	 exceeds	 the	 number	 of	 studies	 included	 (n	=	27).	 Most	 stud-
ies reported PPI for prioritization of research themes/questions 
(n = 10),6,25-28,32,35,43,45,49 followed by development of recruitment 
strategies for research (n = 9),29,31,33,34,38,40,44,47,50 definition of re-
search	 themes/questions	 (n	=	7),6,25,32,38,42,43,45 method development 
(n	=	6),39,41,42,46,48,50 study design development (n = 3),30,36,37 dissemi-
nation strategy (n = 2),38,42 dissemination (n = 2),42,50 analysis (n = 1)50 
and recruitment (n = 1).50 None of the studies involved patients in data 
generation (eg, as interviewers/facilitators).
With regard to PPI methods, the studies included a range of various 
qualitative and quantitative scientific methods (Figure 3). PPI is also de-
scribed in terms of processes that involved workshops, discussions and 
feedback sessions and where patients and carers participated in a va-
riety of consultation, reference and expert groups. Finally, two studies 
use the JLA priority setting process,27,32 which included the establish-
ment of a steering group, surveys and consensus meetings between the 
assorted stakeholders.
3.3 | Purposes and outcomes of PPI
All of the studies show alignment between the PPI purpose and the 
reported outcome. Most studies reflect the democratizing value of 
PPI in research. This is especially clear in studies that aim to identify 
and/or prioritize research topics that describe patient perspectives 
as essential to defining the future research agenda.6,25-28,32,35,43,45,49
In studies designed to develop recruitment strategies, patients 
are involved to optimize and target recruitment, for example, to gain 
insight into patient opinions for clinical trial information materials,47 
to develop more user- friendly clinical trial websites,44 to define best 
time to recruit patients for patient- reported outcome measures 
(PROM) research,29 to develop clinical trial decision aids31,40 and to 
develop the study brand to increase recruitment and retention.34
When PPI is part of developing methods or entire study designs, 
patients and carers are involved to ensure, for instance, the rele-
vance,41 population- specific sensitivity,46 validity50 and ethics37 of 
the methods and study designs. Finally, the purpose of PPI at the 
dissemination stage is to ensure relevant education and information 
that can help reduce health disparities.42
3.4 | PPI challenges and recommendations
During the review, we sought to extract specific PPI challenges 
and recommendations reported in the studies (Table 3). Challenges 
are not reported in all studies, but many of them described gen-
eral methodological challenges and limitations, such as the issue 
of poor generalizability due to the limited number of participants, 
poor response rate25,43,45 or the qualitative design.40 Poor gen-
eralizability was also described in terms of the composition of the 
sample	 or	 included	 participants.	 Studies	 problematized	 the	 over-	
representation of women6,42 and the underrepresentation of ethnic 
minorities (n = 4),6,27,42,46 and patients with an advanced and aggres-
sive illness6,32,48 and newly diagnosed and relapsed patients.43 The 
issue of representativity reflects a classical methodological concern 
in studies that seek variation in their population but also touches 
upon the issue of opportunities to participate in PPI. In addition to 
this challenge, studies problematize the fact that PPI often involves 
the most socioeconomically advantaged patients who are already 
active in patient and consumer organizations47 and the difficulty of 
reaching and engaging less proactive patients34 and patients with a 
low level of health literacy.49
A few studies reflected on specific challenges regarding the in-
volvement of patients and carers in the research process. One study 
revealed that the patients have difficulty focusing on research pri-
orities as opposed to their own illness experiences.25 Another study 
stated that the medical jargon was difficult to understand and that 
patients found that prioritizing research issues was difficult because 
they were perceived as equally important.32 The PPI challenge men-
tioned most often was its time- consuming nature and the surplus 
financial resources required.31,36,42,50
In terms of recommendations, the majority of the studies 
(n = 19) did not have specific recommendations on the PPI process. 
However, PPI has implicit value and the studies recommended that 
engaging patients and carers in the research process is important for 
ethical and practical reasons. A few studies recommended specific 
methods, such as the value- weighting approach as an acceptable and 
feasible method43; the community consultation model for ensuring a 
more ethical design37; focus groups as a valid method for formulating 
research ideas25; and the Delphi method for ensuring transparency 
and equity in the PPI process.42
The specific PPI recommendations included building participant 
competencies for PPI both among the patient/public participants 
and among the participating researchers.45 Improving patient/public 
competencies and skills could include formal training36,39 and en-
suring support from researchers44 and sensitive facilitation during 
the research process as it can be an upsetting experience to talk 
about illness experiences.25 Researchers can improve their ability to 
listen and respond to patient/public needs.44 Rush et al36 stressed 
the importance of creating a respectful relationship, clear roles and 
well- defined responsibilities. Treiman et al39 recommended holding 
separate meetings with researchers and patients. Recommendations 
also included engaging in partnerships with well- established net-
works and projects that were already a consumer priority.44 For pro-
cess recommendations, one study recommended that patient and 
stakeholder involvement should be initiated early in the research 
process.39 Other process- related recommendations were to include 
adequate time for meetings, planning42 and logistics.36	Some	stud-
ies recommended including the following in the budget: care and 
comfort (support, rest, food),50 financial support/compensation,39,42 
cost of extra time and PPI expenditures.36 As described above, rec-
ommendations also involved taking representativity and the lack of 
diversity among PPI participants into consideration (see Table 3).
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TABLE  2 Characteristics of included studies stratified according to research stages (cf. Table 1)
Authors, year, origin Population Methods Participants Purpose Outcome Challenges Recommendations
Research stage: Prioritization of research theme/question 
Included studies (n = 5)
Perkins et al,28 2008, UK Palliative Questionnaire Pt (n = 112) Prioritize	17	research	topics 17	topics	were	prioritized None None
Pilot test Pt (n = 10)
McNair et al,35	2016,	UK Bowel cancer (other bowel 
diseases)
Focus groups Pt (n = 12)  
(Total n=NR)
Explore pts’ view on colorectal 
research and to prioritize 
research topics with pts and the 
public
25 research questions were prioritized None None
Interviews Pt (n = 11)  
(Total n = 25)
Moorcraft et al,26	2016,	
UK
Heterogeneous, mainly 
breast cancer
Survey Pt	(n	=	780) Prioritize 12 research themes 12 predefined research themes were 
prioritized
Representativity: Mainly white and 
middleclass population, who are 
influenced by ongoing research
None
van Merode et al,49	2016,	
The Netherlands
Blood cancer Dialogue Model: Identify top 10 priorities Top 10 questions identified and top 
three stated as research questions
Representativity: Lack of insight 
from pts with low level of health 
literacy
None
Interview Pt (n = 10)
Focus group Pt (n = 20)
Questionnaire Pt	(n	=	789)
Dialogue meeting/project 
group
Pt	(n	=	6)
Wan et al,27	2016,	UK Endometrial cancer James Lind Alliance 
priority setting process: 
Identify top 10 unanswered 
research questions
10 research questions identified Representativity: Ethnic minorities 
and	+60	y	women	are	
under- represented
None
Steering	group	(pts/other	
stakeholders)
(n = NR)
Survey	1 Pt	(n	=	177) 
(Total n = 413)
Survey	2 Pt (n = NR) 
(Total n = 113)
Consensus meeting Pt (n = NR) 
(Total n = 23)
Research stage: Definition of research themes/questions 
Included studies (n = 5)
Corner et al,6	2007,	UK Heterogeneous Focus group Pt (n = 105) Reach consensus on research 
priorities
15 research themes identified and 
prioritized
Representativity: Few men, ethnic 
minorities and pts with aggressive 
tumours included
To compare the priorities to with the views of the public, people 
bereaved by cancer, and patients in other contexts such as resource 
poor countries
Perkins et al,25	2007,	UK Palliative Focus group Pt (n = 19) Identify key priorities for future 
research
5 research themes identified Maintaining pts focus on research 
priorities (not their own illness 
experiences)
Sensitive	facilitation	when	dealing	with	critically	ill	participants
Focus groups are a valid method for developing research ideas
Clinton- Macharg et al,43 
2010, Australia
Haematology Delphi method Pt (n = 2) Develop and prioritize research 
items
Research items prioritized Representativity: Under- 
representation of newly 
diagnosed and relapsed pts
The value- weighting approach represents an acceptable and feasible way 
to quantify stakeholder perceptions on the allocation of research 
resources
Survey 
(+Pilot test)
Pt (n = 10) 
(n = NR)
Saunders	et	al,45 2012, 
Australia
Heterogeneous Workshop Pt (n = 32) Identify top 5 cancer research 
needs
Top 4 research needs identified None Build consumer and researcher PPI skills
Survey Pt	(n	=	57)
Stephens	et	al,32 2015, 
UK
Mesothelioma (lung 
cancer)
James Lind Alliance 
priority setting 
partnership/process:
Agree on top 10 interventional 
research priorities
52 unique unanswered research 
questions identified 
Top 10 research questions stated
Pts have short survival, difficult to 
recruit pts for steering group 
 Pts find medical jargon difficult 
to understand 
 Pts find prioritization difficult 
(research issues equally 
important)
None
Steering	group Pt (n = 2) 
Carers (n = 2)
Survey Pt (n = 103)  
Carers (n = 242)
Interim prioritization 
survey
Pt (n = 38)  
Carers (n = 98)
Consensus meeting Pt	(n	=	6)	 
Carers (n = 4)
(Continues)
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15 research themes identified and 
prioritized
Representativity: Few men, ethnic 
minorities and pts with aggressive 
tumours included
To compare the priorities to with the views of the public, people 
bereaved by cancer, and patients in other contexts such as resource 
poor countries
Perkins et al,25	2007,	UK Palliative Focus group Pt (n = 19) Identify key priorities for future 
research
5 research themes identified Maintaining pts focus on research 
priorities (not their own illness 
experiences)
Sensitive	facilitation	when	dealing	with	critically	ill	participants
Focus groups are a valid method for developing research ideas
Clinton- Macharg et al,43 
2010, Australia
Haematology Delphi method Pt (n = 2) Develop and prioritize research 
items
Research items prioritized Representativity: Under- 
representation of newly 
diagnosed and relapsed pts
The value- weighting approach represents an acceptable and feasible way 
to quantify stakeholder perceptions on the allocation of research 
resources
Survey 
(+Pilot test)
Pt (n = 10) 
(n = NR)
Saunders	et	al,45 2012, 
Australia
Heterogeneous Workshop Pt (n = 32) Identify top 5 cancer research 
needs
Top 4 research needs identified None Build consumer and researcher PPI skills
Survey Pt	(n	=	57)
Stephens	et	al,32 2015, 
UK
Mesothelioma (lung 
cancer)
James Lind Alliance 
priority setting 
partnership/process:
Agree on top 10 interventional 
research priorities
52 unique unanswered research 
questions identified 
Top 10 research questions stated
Pts have short survival, difficult to 
recruit pts for steering group 
 Pts find medical jargon difficult 
to understand 
 Pts find prioritization difficult 
(research issues equally 
important)
None
Steering	group Pt (n = 2) 
Carers (n = 2)
Survey Pt (n = 103)  
Carers (n = 242)
Interim prioritization 
survey
Pt (n = 38)  
Carers (n = 98)
Consensus meeting Pt	(n	=	6)	 
Carers (n = 4)
(Continues)
10  |     PII et al.
Authors, year, origin Population Methods Participants Purpose Outcome Challenges Recommendations
Research stage: Development of recruitment/retention strategies for research projects 
Included	studies	(n	=	7)
Dellson et al,47 2010, 
Sweden
Breast cancer Focus group Pt (n = 5) Gain	insight	to	pts’	opinions	
about clinical trial information 
material
Recommendations for clinical trial 
information material  
Pts give new insights, simple 
improvements that may increase 
readability/recruitment
Representativity:  
Informants already active in 
cancer association 
Less proactive informants not 
represented
None
Questionnaire (validation) Pt (n = 18)
Dear et al,44 2011, 
Australia
Heterogeneous Consumer reference group 
discussions
Consumers (n = 11) Develop user- friendly clinical 
trial website
Consumer input is implemented in 
design of website
None Working with well- established consumer networks and projects that 
already are consumer priorities 
 Researchers listen/respond to consumer needs 
 Researchers support consumer groups
Survey(evaluation) Pt	(n	=	47) Survey	(evaluation):	89%	of	47	pts	rated	
the website as good
Ashley et al,29 2012, UK Heterogeneous (breast, 
colorectal, prostate)
Individual and group 
interviews
Pt (n = 15) Define best time for recruiting 
pts for PROM- based research 
(psychosocial)
Preferable time found Representativity:	Sample	did	not	
include ethnic minorities, and 
people with advanced cancer 
disease
None
HP (n = 15)
Wells et al,40	2012,	US Heterogeneous Interview Pt (n = 18) Develop clinical trial decision aid A multi- media, psycho- educational 
intervention for clinical trials
None None
Pre- test Pt/carers (n = 20)
Fleisher et al,31 2014, UK Heterogeneous Focus groups Pt/pt advocates (n = 22) Develop digital decision aid tool 
to improve preparation for 
decision making in cancer trials
A high quality, pt- centred decision aid Labour intensive and time 
consuming
None
Feedback/video 
development
Pt (n = 5)
Taylor et al,34 2015, UK Heterogeneous, young 
(14-	26	y)
Workshop Pt (n = 9) Develop research project brand 
to increase recruitment and 
retention
Higher acceptance and retention in 
study	than	expected	(80%	vs	60%)	
Lower refusal rate than expected 
(<20%	vs	35%)
None None
Survey Pt (n = 249)
Taylor et al,33	2016,	UK Heterogeneous, young 
(14-	26	y)
Workshop (incl. focus 
groups, individual 
reflections and creative 
interpretation)
Pt (n = 8) Elicit young people’s views on 
access and participation in 
research to inform recruitment 
for research project
3 important recruitment themes 
described
Representativity: Engaging less 
proactive pts
None
	Survey Pt (n = 222)
Research stage: Development of methods
Included studies (n = 4)
Vivat et al,46 2012, UK, 
Germany,	Italy,	Iceland,	
Japan,	Spain
Palliative cancer Interview Pt (n = 22) Develop cross- cultural 
questionnaire on spiritual 
well- being among palliative 
cancer pts
A well- tested cross- cultural question-
naire	(EORTC	QLQ-	SWB36)
Representativity: Few ethnic 
minorities participated
None
Survey:	Pre-	pilot	test Pt	(n	=	17)
Pilot test Pt (n = 113)
McCarrier et al,41	2016,	
US
Lung cancer Interviews Pt (n = 51) Develop a new symptoms- based 
patient- reported outcome 
(PRO) instrument
PRO instrument developed according to 
pt responses and feedback
None None
Interviews Pt (n = 20)
Treiman et al,39	2016,	US Colorectal cancer PCORI conceptual model: 
Advisory board
Pt	(n	=	7) Develop and test survey 
questions
Survey	developed	according	to	pt	input None Involve pts/stakeholders as early as possible 
 Find “common language” to ensure effective communication between 
researchers and PPI participants 
Train pts  
Hold separate meetings with pts 
 Provide remuneration for pts
Pre- test: online survey Pt (n = 23)
Interview Pt	(n	=	17)
Sperling	et	al,48	2016,	
Denmark
Heterogeneous, adoles-
cents and young adults 
(17-	38	y)
Interview/focus group Pt (n = 21) Develop a new national 
questionnaire targeting 
adolescents and young adults 
with cancer aiming to evaluate 
treatment and survivorship 
from the perspective of the pts 
and to reflect their needs and 
experiences throughout the 
cancer trajectory
New questionnaire developed Representativity: More disadvan-
taged/ill pts did not participate
None
Pt panel Pt (n = 9)
Interview Pt (n = 11)
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Authors, year, origin Population Methods Participants Purpose Outcome Challenges Recommendations
Research stage: Development of recruitment/retention strategies for research projects 
Included	studies	(n	=	7)
Dellson et al,47 2010, 
Sweden
Breast cancer Focus group Pt (n = 5) Gain	insight	to	pts’	opinions	
about clinical trial information 
material
Recommendations for clinical trial 
information material  
Pts give new insights, simple 
improvements that may increase 
readability/recruitment
Representativity:  
Informants already active in 
cancer association 
Less proactive informants not 
represented
None
Questionnaire (validation) Pt (n = 18)
Dear et al,44 2011, 
Australia
Heterogeneous Consumer reference group 
discussions
Consumers (n = 11) Develop user- friendly clinical 
trial website
Consumer input is implemented in 
design of website
None Working with well- established consumer networks and projects that 
already are consumer priorities 
 Researchers listen/respond to consumer needs 
 Researchers support consumer groups
Survey(evaluation) Pt	(n	=	47) Survey	(evaluation):	89%	of	47	pts	rated	
the website as good
Ashley et al,29 2012, UK Heterogeneous (breast, 
colorectal, prostate)
Individual and group 
interviews
Pt (n = 15) Define best time for recruiting 
pts for PROM- based research 
(psychosocial)
Preferable time found Representativity:	Sample	did	not	
include ethnic minorities, and 
people with advanced cancer 
disease
None
HP (n = 15)
Wells et al,40	2012,	US Heterogeneous Interview Pt (n = 18) Develop clinical trial decision aid A multi- media, psycho- educational 
intervention for clinical trials
None None
Pre- test Pt/carers (n = 20)
Fleisher et al,31 2014, UK Heterogeneous Focus groups Pt/pt advocates (n = 22) Develop digital decision aid tool 
to improve preparation for 
decision making in cancer trials
A high quality, pt- centred decision aid Labour intensive and time 
consuming
None
Feedback/video 
development
Pt (n = 5)
Taylor et al,34 2015, UK Heterogeneous, young 
(14-	26	y)
Workshop Pt (n = 9) Develop research project brand 
to increase recruitment and 
retention
Higher acceptance and retention in 
study	than	expected	(80%	vs	60%)	
Lower refusal rate than expected 
(<20%	vs	35%)
None None
Survey Pt (n = 249)
Taylor et al,33	2016,	UK Heterogeneous, young 
(14-	26	y)
Workshop (incl. focus 
groups, individual 
reflections and creative 
interpretation)
Pt (n = 8) Elicit young people’s views on 
access and participation in 
research to inform recruitment 
for research project
3 important recruitment themes 
described
Representativity: Engaging less 
proactive pts
None
	Survey Pt (n = 222)
Research stage: Development of methods
Included studies (n = 4)
Vivat et al,46 2012, UK, 
Germany,	Italy,	Iceland,	
Japan,	Spain
Palliative cancer Interview Pt (n = 22) Develop cross- cultural 
questionnaire on spiritual 
well- being among palliative 
cancer pts
A well- tested cross- cultural question-
naire	(EORTC	QLQ-	SWB36)
Representativity: Few ethnic 
minorities participated
None
Survey:	Pre-	pilot	test Pt	(n	=	17)
Pilot test Pt (n = 113)
McCarrier et al,41	2016,	
US
Lung cancer Interviews Pt (n = 51) Develop a new symptoms- based 
patient- reported outcome 
(PRO) instrument
PRO instrument developed according to 
pt responses and feedback
None None
Interviews Pt (n = 20)
Treiman et al,39	2016,	US Colorectal cancer PCORI conceptual model: 
Advisory board
Pt	(n	=	7) Develop and test survey 
questions
Survey	developed	according	to	pt	input None Involve pts/stakeholders as early as possible 
 Find “common language” to ensure effective communication between 
researchers and PPI participants 
Train pts  
Hold separate meetings with pts 
 Provide remuneration for pts
Pre- test: online survey Pt (n = 23)
Interview Pt	(n	=	17)
Sperling	et	al,48	2016,	
Denmark
Heterogeneous, adoles-
cents and young adults 
(17-	38	y)
Interview/focus group Pt (n = 21) Develop a new national 
questionnaire targeting 
adolescents and young adults 
with cancer aiming to evaluate 
treatment and survivorship 
from the perspective of the pts 
and to reflect their needs and 
experiences throughout the 
cancer trajectory
New questionnaire developed Representativity: More disadvan-
taged/ill pts did not participate
None
Pt panel Pt (n = 9)
Interview Pt (n = 11)
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Authors, year, origin Population Methods Participants Purpose Outcome Challenges Recommendations
Research stage: Development of entire study design 
Included studies (n = 3)
Freysteinson,37	2010,	US Breast cancer Case study/community 
consultation model
Pt (n = 24)  
	HP	(n	=	16)
Explore community perspective 
on legitimacy, benefits, 
protection and partnership in 
research idea
Insights into the study design: legitimacy, 
benefits, protection and partnership 
A more ethical research design
None Community consultation model recommended for a more ethical 
research design
Ellis et al,30 2012, UK Lung cancer Interview Pt	(n	=	37)	 
Carers (n = 23)
Identify pts and carers views on 
the desirable components of a 
novel nonpharmacological 
intervention
Key issues on development, delivery and 
uptake of a novel intervention (next 
step is to pilot test)
None None
Rush et al,36	2015,	US Breast cancer Latino Community- based 
organization partners 
Advisory board 
Feedback
Pt (n = NR) Develop a culturally sensitive 
quality- of- life survivor- 
caregiver intervention (RCT)
Intervention/RCT developed, including 
survey
None (but implicitly addressed in 
recommendations/lessons 
learned)
Lessons learned:  
Establish trusting/respectful relationships 
 Be receptive to what is already being done in the community 
 Have a plan for addressing questions and conflicts 
 Use democratic approaches for decision making 
 Clear roles and responsibilities 
 Communicate regularly with whole team to promote team cohesion 
 Ensure that study files/procedures are clear and accessible to all 
collaborators 
 Be prepared to spend time educating team members on study process/
design 
 Offer training that meets partner needs 
 Be prepared for higher administrative burden due to large team 
Be flexible
Multiple research stages: Development of recruitment/retention strategies for research projects, Development of methods, Development of  
entire study design, Participation in recruitment, Participation in data analysis, Dissemination of research Included studies (n = 1)
Chiu et al,50 2013, Canada Breast cancer Pilot interviews Pt	(n	=	6) Develop study design (survey 
package) to increase validity, 
enhance ethics and gain high 
response rate
Study	design	(survey	package)	developed	
and validated by pts 
	High	survey	response	rate	(81%)
Potential risk of participants 
rejecting design/method delaying 
project and increasing the cost
Include cost of care and comfort (support, rest, food) in budgets
Community advisory group Pt (n = 5)
Workshop Pt (n = 18)
Pt interviews also 
conducted, but served as 
data
Pt	(n	=	46)
Survey Pt (n = 500)
Multiple research stages: Definition of research themes/questions, Development of recruitment/retention strategies for research projects,  
Develop dissemination strategy 
Included studies (n = 1)
Islam et al,38	2014,	US Lung cancer Focus groups Pt	(n	=	7)	 
	(Total	n	=	36)
Define focus for pt- centred 
outcome research (define 
treatment success) and gain 
insight into research recruit-
ment/retention and 
dissemination
Pt- centred treatment success defined by 
pts/stakeholders 
 Insights into research recruitment/
retention and dissemination
None None
Multiple research stages: Definition of research themes/questions, Prioritisation of research themes/questions, Development of methods,  
Dissemination of research, Develop dissemination strategy 
Studies	included	(n	=	1)
Vargas et al,42	2014,	US Heterogeneous CPPR model/community- 
academic council 
 Modified Delphi
Pt	28%	of	36	members	
approx. (n = 10)
Form CPPR model to promote 
cancer research and develop 
activities/products (eg, 
education/information) that 
reduce cancer disparities
CPPR model led to: Conferences 
(dissemination of research)  
New survey instrument 
New research projects 
Funding  
Education
Representativity: Under- 
representation of male and Latino 
population (mostly Afro- 
American women participated)
Delphi method ensures transparency and equity in development of action 
 Ensure financial support for all partners 
 Ensure time for meetings and planning
CPPR, Community partnered- participatory research; HPs, health professionals; NR, not reported; Pt, patient (Pts = Patients); PPI,  
Patient and public involvement; PRO, patient- reported outcome; PCORI, Patient- Centered Outcomes Research Institute; RCT,  
Randomized	controlled	trial;	EORTC	QLQ-	SWB36,	European	Organisation	for	Research	and	Treatment	of	Cancer-	 
Quality	of	Life	Questionnaire-	Spiritual	wellbeing	(36	items).
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Authors, year, origin Population Methods Participants Purpose Outcome Challenges Recommendations
Research stage: Development of entire study design 
Included studies (n = 3)
Freysteinson,37	2010,	US Breast cancer Case study/community 
consultation model
Pt (n = 24)  
	HP	(n	=	16)
Explore community perspective 
on legitimacy, benefits, 
protection and partnership in 
research idea
Insights into the study design: legitimacy, 
benefits, protection and partnership 
A more ethical research design
None Community consultation model recommended for a more ethical 
research design
Ellis et al,30 2012, UK Lung cancer Interview Pt	(n	=	37)	 
Carers (n = 23)
Identify pts and carers views on 
the desirable components of a 
novel nonpharmacological 
intervention
Key issues on development, delivery and 
uptake of a novel intervention (next 
step is to pilot test)
None None
Rush et al,36	2015,	US Breast cancer Latino Community- based 
organization partners 
Advisory board 
Feedback
Pt (n = NR) Develop a culturally sensitive 
quality- of- life survivor- 
caregiver intervention (RCT)
Intervention/RCT developed, including 
survey
None (but implicitly addressed in 
recommendations/lessons 
learned)
Lessons learned:  
Establish trusting/respectful relationships 
 Be receptive to what is already being done in the community 
 Have a plan for addressing questions and conflicts 
 Use democratic approaches for decision making 
 Clear roles and responsibilities 
 Communicate regularly with whole team to promote team cohesion 
 Ensure that study files/procedures are clear and accessible to all 
collaborators 
 Be prepared to spend time educating team members on study process/
design 
 Offer training that meets partner needs 
 Be prepared for higher administrative burden due to large team 
Be flexible
Multiple research stages: Development of recruitment/retention strategies for research projects, Development of methods, Development of  
entire study design, Participation in recruitment, Participation in data analysis, Dissemination of research Included studies (n = 1)
Chiu et al,50 2013, Canada Breast cancer Pilot interviews Pt	(n	=	6) Develop study design (survey 
package) to increase validity, 
enhance ethics and gain high 
response rate
Study	design	(survey	package)	developed	
and validated by pts 
	High	survey	response	rate	(81%)
Potential risk of participants 
rejecting design/method delaying 
project and increasing the cost
Include cost of care and comfort (support, rest, food) in budgets
Community advisory group Pt (n = 5)
Workshop Pt (n = 18)
Pt interviews also 
conducted, but served as 
data
Pt	(n	=	46)
Survey Pt (n = 500)
Multiple research stages: Definition of research themes/questions, Development of recruitment/retention strategies for research projects,  
Develop dissemination strategy 
Included studies (n = 1)
Islam et al,38	2014,	US Lung cancer Focus groups Pt	(n	=	7)	 
	(Total	n	=	36)
Define focus for pt- centred 
outcome research (define 
treatment success) and gain 
insight into research recruit-
ment/retention and 
dissemination
Pt- centred treatment success defined by 
pts/stakeholders 
 Insights into research recruitment/
retention and dissemination
None None
Multiple research stages: Definition of research themes/questions, Prioritisation of research themes/questions, Development of methods,  
Dissemination of research, Develop dissemination strategy 
Studies	included	(n	=	1)
Vargas et al,42	2014,	US Heterogeneous CPPR model/community- 
academic council 
 Modified Delphi
Pt	28%	of	36	members	
approx. (n = 10)
Form CPPR model to promote 
cancer research and develop 
activities/products (eg, 
education/information) that 
reduce cancer disparities
CPPR model led to: Conferences 
(dissemination of research)  
New survey instrument 
New research projects 
Funding  
Education
Representativity: Under- 
representation of male and Latino 
population (mostly Afro- 
American women participated)
Delphi method ensures transparency and equity in development of action 
 Ensure financial support for all partners 
 Ensure time for meetings and planning
CPPR, Community partnered- participatory research; HPs, health professionals; NR, not reported; Pt, patient (Pts = Patients); PPI,  
Patient and public involvement; PRO, patient- reported outcome; PCORI, Patient- Centered Outcomes Research Institute; RCT,  
Randomized	controlled	trial;	EORTC	QLQ-	SWB36,	European	Organisation	for	Research	and	Treatment	of	Cancer-	 
Quality	of	Life	Questionnaire-	Spiritual	wellbeing	(36	items).
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3.5 | Quality assessment
Studies	with	a	qualitative	design	were	assessed	according	to	CASP	
(n = 13) which was chosen because of its thorough examination 
of	 the	quality	of	qualitative	 research	 (Appendix	S1)	and	because	
it has been used in similar systematic reviews of PPI.19,20,51 The 
CASP	 assessment	 showed	 that	 the	majority	 of	 the	 studies	were	
of	high	quality.	Studies	that	were	of	low	quality	did	not	apply	the	
scientific methods generally applied in qualitative research (eg, 
expert panel discussions and workshops)33,42 and did not fulfil 
the	CASP	 criteria	 to	 the	 same	degree	 as	 the	other	 studies.	One	
of	the	criteria	that	CASP	assesses	is	whether	the	relationship	be-
tween the researcher and participants has been critically exam-
ined. This includes researchers examining their own role, potential 
bias and influence on, for example, defining the research topic, 
data collection, recruitment and choice of location, but also how 
the researcher responded to events during the study and whether 
changes in the research design were considered. Despite the fact 
that this issue is a key aspect of PPI, many studies (n = 9) failed to 
meet	the	criteria.	(Appendix	S1)
The remaining quantitative descriptive and mixed methods 
studies (n = 14) were evaluated using MMAT, an instrument 
developed for mixed- study reviews. We found variation in the 
quality assessments of the studies, where low quality assess-
ments in the quantitative studies were related to issues regard-
ing response rate. Low quality assessment of the qualitative 
studies mainly regarded the lack of description of researchers’ 
influence	 (in	 line	with	 the	CASP	 assessment	 of	 the	 qualitative	
studies).	 In	both	 the	MMAT	and	CASP	assessment,	 low	quality	
was often found in studies applying methods such as reference 
groups and other participatory research processes that were 
poorly described and therefore difficult to evaluate for quality 
(Appendix	S1).
4  | DISCUSSION
This review presented central aspects of PPI in cancer research 
based on an appraisal of relevant literature over the past decade to 
explore current trends and provide information for future PPI in can-
cer research. In the following, we summarize and discuss the findings 
by relating them to the broader PPI literature and point out implica-
tions for future PPI practice in cancer research.
4.1 | PPI participants
Internationally, the frontrunners of PPI in cancer research continue 
to	be	the	UK	and	the	United	States,	followed	by	Australia,	at	least	
in terms of publications. This reflects the general trend of PPI activi-
ties4,19 and is related to the strong organizational and policy founda-
tion PPI has employed in these countries over a long period. The 
few publications (n = 5) originating from other countries indicated 
that	PPI	 in	cancer	research	outside	the	UK,	 the	United	States	and	
Australia is still in its early stages.
Patient and public involvement population trends in cancer re-
search have changed compared to the findings presented in earlier 
reviews,5,22 where PPI activities predominantly took place in breast 
cancer research. The present review showed that a variety of diverse 
patient groups (when defined by cancer diagnosis) are involved in 
PPI activities. Moreover, cancer patients in palliative care25,28,46 and 
with short survival32 have been involved in research development, 
demonstrating that even patients at end of life are able and willing to 
participate. The review identified other ways to define PPI popula-
tion groups in cancer research, for example, according to age33,34,48 
or community/ethnicity.36 Our findings nonetheless call for paying 
critical attention to the composition of PPI participants, which cur-
rently in cancer research primarily continues to be well- educated fe-
male participants from ethnic majority groups who are often already 
F IGURE  2 Patient and public involvement at different research stages
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proactive in patient and community organizations. This point has 
been	made	and	discussed	in	other	reviews.	Green	found	that	certain	
groups (eg, youth, males and black and ethnic minorities) are often 
under- represented in PPI in health research.52 However, Boote et al1 
found that the population groups that were mostly involved in PPI 
in health research were black and minority ethnic groups followed 
by people with mental health problems, children and other “vulner-
able” adults. While the findings by Boote et al demonstrate that PPI 
is practised in groups that in different ways may be categorized as 
vulnerable	 or	marginalized,	 the	 findings	 in	Green	 and	 the	 present	
review indicate that there is a lack of diversity among participants of 
PPI in other, for example, disease- specific, research.
4.2 | Research stages and methods
The review showed that studies have increasingly included PPI in the 
early stages of research. According to the earliest study included in 
the review, patient involvement in determining research priorities, 
especially in cancer research, was lacking and no comprehensive at-
tempt was made to elicit patient views to inform the strategic direc-
tion of cancer research in the UK.6 Our review demonstrated that 
this aspect of PPI in cancer research has gradually grown in the last 
ten years; it has in fact become the research stage at which most 
PPI activities in cancer research take place internationally, espe-
cially in the UK. Although this is a positive development, our review 
shows that PPI is lacking in other research stages and that there are 
few examples of PPI being carried out at several research stages or 
throughout the entire research process. This finding is not isolated 
to cancer research, and similar findings have been found in other 
systematic reviews of PPI,1,13,53-55 which points out a central area for 
development of PPI in general.
An initial aim of our review was to make recommendations re-
garding methods and approaches to practising PPI across the re-
search process. This has proven difficult for two reasons. First, PPI 
methods vary greatly and include scientific, process- oriented and 
mixed approaches (eg, the JLA approach). We assessed the scien-
tific	quality	of	the	studies	according	to	CASP	and	MMAT	and	found	
that studies that have a high methodological quality, for example, do 
not	necessarily	report	clearly	on	the	PPI	process.	Similarly,	studies	
whose methodological quality is low (due to a non- scientific meth-
odological approach) may describe the PPI process in greater detail. 
This puts into question the relevance of using appraisal tools devel-
oped for scientific methods when evaluating PPI studies. Another 
impediment to making recommendations based on experiences 
from other studies is the lack of critical reflection in the articles on 
the methods and PPI process applied. This is in line with other sys-
tematic reviews that have described the reporting of PPI as poor, 
inconsistent and lacking details on context, process, impact and con-
ceptualization of PPI,19-21,56,57 which makes methodological recom-
mendations difficult.13
The PPI literature addresses the challenge of synthesizing re-
sults from PPI articles to inform best practice, just as evaluation and 
reporting guidelines have been developed to support the reporting 
and comparability of PPI in research.18,51,58,59 The recently updated 
version	of	the	Guidance	for	Reporting	Involvement	of	Patients	and	
the	Public	(GRIPP2)	comprises	a	short	and	long	form.	The	latter	can	
be used if reporting PPI is the primary objective of an article, while 
the former is useful for PPI as an integrative part of the research.59 
The short form makes it possible to report on PPI while also report-
ing on the primary research objective based on conventional scien-
tific	criteria,	as	is	the	case	with	CASP	and	MMAT.	The	hope	is	that	
such tools will improve the comparability of future reporting on PPI, 
thereby allowing systematic reviews to inform best practice.
4.3 | Purposes and outcomes of PPI
All of the included studies reported alignment between their specific 
purpose and outcome, pinpointing either the democratic value or re-
search value, or both. The majority of the studies practised PPI at the 
research stage “Development of research focus,” which includes the 
F IGURE  3 Methods applied for patient and public involvement
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definition and prioritization of research topics/questions. These stud-
ies clearly represented the democratic value of PPI, as expressed by 
van Merode et al49 “to formulate through a ‘bottom- up’ approach orig-
inal, relevant and realistic research goals, based on needs as conveyed 
by the patients”. However, since only a handful of studies reported 
that the prioritization of research has led to actual research projects, 
it is difficult to evaluate the democratic impact of PPI at this research 
stage. The prioritization of research has the potential to ensure pa-
tient/public partnerships and even lay- leadership (cf. INVOLVE),10 but 
it depends on realizing the research priorities defined by patients/the 
public. If the research topics are not investigated, it can be argued that 
applying PPI to develop the research focus is a tokenistic activity.9 In 
relation to the discussion of the democratic value of recent PPI activi-
ties in cancer research, there are notably few examples of patient- led 
research (Dear et al44 and van Merode et al49 are exceptions), which 
again reflects the general trend in PPI.4	Studies	that	examine	how	to	
enhance the quality of research predominantly focus on developing 
strategies to improve recruitment of study participants. The value of 
this purpose of PPI has been criticized for being too narrow.60
There are also studies that reflect both democratic and research- 
oriented	values	in	their	stated	purpose	and	outcomes.	Studies	focusing	
on method development argue that PPI ensures patient/public rele-
vance	 and	 enhances	 validity	 in	 research.	 Similarly,	 studies	 involving	
patients/public throughout the research process also reflect demo-
cratic and research- oriented values.37,38,42,50 Islam et al,38 for example, 
demonstrated that the outcomes of PPI include a patient- centred defi-
nition of outcomes, insight into research recruitment/retention and a 
relevant dissemination strategy. Chui et al50 found that the outcomes 
are increased validity, enhanced ethics and a high response rate.
By extracting the purpose and outcomes of PPI in the studies, 
we have attempted to identify the research- oriented impact of 
PPI. However, the impact of PPI may also include the impact on the 
people involved (the patients/public, stakeholders, researchers), 
the wider community/community organizations and impact on 
implementation and change.19,21 These kinds of impact have also 
been	included	in	the	GRIPP2	checklist59 to improve the reporting 
of PPI and thus the grounds for discussing and evaluating the im-
pact of PPI. The recent year’s debate about the impact of PPI has 
called for more detailed descriptions about the context and mech-
anisms of PPI to enhance our understanding of when, why and how 
it works.21,55 It has been argued that the experiential knowledge 
of researchers and patients/the public is essential for understand-
ing the complexity of the PPI collaboration and process and thus 
for the evaluation of the impact of different PPI approaches.21 In 
the present review, the majority of studies do not describe par-
ticipants’ experiences or evaluation of their PPI participation and 
when provided, the descriptions are minimal.25,33,38,50,61
4.4 | Challenges and recommendations
As described, most studies do not explicitly report challenges or 
recommendations on the PPI process based on their experiences. 
General	methodological	challenges	and	limitations	are	reported,	but	C
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they do not specifically inform future PPI in cancer research. Likewise, 
general PPI recommendations, such as “we must involve patients in 
setting the research agenda”,28 or “Ideally consumers and research-
ers should always work together to identify and detail research top-
ics”45 are also too vague to inform future PPI activities. The type of PPI 
challenges reported in other studies regarding, for example, conflicts 
among community concerns and research agendas and power rela-
tions between PPI participants and researchers19 were absent. This 
lack of critical attention is also identified in other systematic reviews of 
PPI, labelling it as a “publication bias”.19 This lack of critical discussion 
on the process and outcomes of PPI increases the risk of tokenism.
The studies in our review that more specifically address PPI challenges 
and recommendations confirm issues identified in other PPI reviews such 
as budgeting for extra costs and time spent,13,56 as well as building com-
petencies, skills and relationships,54,56 and taking the composition of PPI 
participants into consideration, as discussed earlier. A handful of studies 
report specific challenges associated with involving patients with ad-
vanced and aggressive disease, where, for example, recruitment to panels 
and boards is difficult due to high patient mortality.32 Another specific 
recommendation for involving seriously ill people is to consider their spe-
cial care needs, for example, being able to rest when participating in focus 
group discussions50 and ensuring sensitive facilitation during the research 
process, as it can be upsetting for the participating patient.25
4.5 | PPI in cancer research and other medical fields
The findings of the present review describe the progress of PPI in can-
cer research within the last ten years, which demonstrates a continuous 
engagement in qualifying PPI. Compared to systematic reviews regard-
ing PPI in other (medical) research areas, there are many similarities, as 
demonstrated in the discussion. There are, however, also additional in-
sights that may have general relevance for PPI in other (medical) fields.
One of the findings the review shows that it is feasible and valu-
able to involve patients in research even when the survival rate is 
low and end of life near. This finding is particularly relevant for re-
search in cancer and other life- threatening diseases, but may also 
inspire the inclusion of patients who are in other ways perceived as 
being too vulnerable to participate in PPI. Another finding which 
has general relevance regards the composition of the participants 
in PPI activities, where the review shows that there is a growing 
critical awareness of the overrepresentation of certain groups, that 
is, women from socioeconomically advantaged and ethnic majority 
groups, who are often already proactive patients.
4.6 | Implications for practice
The current trends identified in this systematic review point towards 
several areas that can be further developed within PPI in cancer re-
search. Based on the findings of the review, we recommend that:
• PPI activities are expanded in countries besides the ones cur-
rently predominant in the field to generate international diversity 
in PPI in cancer research.
•	 Greater	diversity	is	ensured	in	the	composition	of	PPI	participants	
regarding gender, ethnicity, health literacy, education and socio-
economically status.
• PPI activities go beyond the first stage of the research process 
“Development of research focus,” where PPI has become well es-
tablished, to explore the potential of PPI more broadly through-
out the research process.
• PPI reporting is qualified by including positive and negative expe-
riences of the PPI process to inform future PPI, for example, by 
using	GRIPP2.
• The special needs and preferences of seriously ill participants are 
considered to allow their participation in PPI activities.
4.7 | Limitations
Our search strategy was limited to three scientific databases with-
out grey literature searches. However, we were especially interested 
in reviewing peer- reviewed PPI activities to ensure a standard for 
scientific quality.
It could be argued that it is a limitation that no patient or other 
public participant was involved in conducting the review. The reason 
for this is that the competencies needed to carry out a systematic re-
view would require an introduction to the methodology and training, 
which was not feasible based on the scope of this review.
The assessment of the studies should be read with caution. As 
earlier discussed, some studies that are assessed to have a low stan-
dard	of	quality	according	to	CASP	and	MMAT	present	thorough	de-
scriptions of the PPI process.
5  | CONCLUSION
This systematic review described and discussed the current state of 
the international empirical literature on PPI in cancer research. PPI in 
cancer research has especially been integrated in the early stages of 
the research process, with most studies involving patients/the pub-
lic in defining and prioritizing research. Involving patients/the public 
at this research stage is a strong democratic signal; however, if the 
research is not realized, PPI may risk becoming a token activity. As 
a result, we recommend that the reporting on PPI includes critical 
reflections regarding PPI methods and outcomes to avoid tokenism. 
Reporting on the positive and negative experiences of PPI will con-
tribute to the further development of PPI and its potential.
CONFLIC T OF INTERE S T
The authors declare that they have no conflict of interest.
ORCID
Kathrine Hoffmann Pii  http://orcid.org/0000-0002-2283-129X 
Karin Piil  http://orcid.org/0000-0001-7972-4674 
     |  19PII et al.
Lone Helle Schou  http://orcid.org/0000-0002-5465-6246 
Mary Jarden  http://orcid.org/0000-0003-3040-8384     
R E FE R E N C E S
 1. Boote J, Wong R, Booth A. ‘Talking the talk or walking the walk?’ 
A bibliometric review of the literature on public involvement in 
health research published between 1995 and 2009. Health Expect. 
2015;18(1):44-57.
	 2.	 Locock	L,	Boylan	A-M,	Snow	R,	Staniszewska	S.	The	power	of	sym-
bolic capital in patient and public involvement in health research. 
Health Expect.	2016;20(5):836-844.
	 3.	 Forbat	L,	Hubbard	G,	Kearney	N.	Patient	and	public	 involvement:	
models and muddles. J Clin Nurs.	2009;18(18):2547-2554.
	 4.	 Sacristán	JA,	Aguarón	A,	Avendaño-Solá	C,	et	al.	Patient	 involve-
ment in clinical research: why, when, and how. Patient Prefer 
Adherence.	2016;10:631-640.
	 5.	 Hubbard	G,	Kidd	L,	Donaghy	E,	McDonald	C,	Kearney	N.	A	review	of	
literature about involving people affected by cancer in research, pol-
icy and planning and practice. Patient Educ Couns.	2007;65(1):21-33.
	 6.	 Corner	 J,	Wright	 D,	 Hopkinson	 J,	 Gunaratnam	 Y,	McDonald	 JW,	
Foster C. The research priorities of patients attending UK cancer 
treatment centres: findings from a modified nominal group study. 
Br J Cancer.	2007;96(6):875-881.
	 7.	 Madden	M,	Morley	R.	Exploring	 the	challenge	of	health	 research	
priority setting in partnership: reflections on the methodology 
used	 by	 the	 James	 Lind	 Alliance	 Pressure	 Ulcer	 Priority	 Setting	
Partnership. Res Involv Engagem.	2016;2(1):12.
	 8.	 Oliver	SR,	Rees	RW,	Clarke-Jones	L,	et	al.	A	multidimensional	con-
ceptual framework for analysing public involvement in health ser-
vices research. Health Expect.	2008;11(1):72-84.
	 9.	 Arnstein	 SR.	 A	 ladder	 of	 citizen	 participation.	 J Am Plan Assoc. 
1969;35(4):216-224.
 10. INVOLVE. Briefing Notes for Researchers: Involving the Publicin NHS, 
Public Health and Social Care Research. Eastleigh; 2012.
 11. Health Canada. Health Canada Policy Toolkit for Public Involvement in 
Decision Making. Ottawa, ON; 2000.
	12.	 South	A,	Hanley	B,	Gafos	M,	et	al.	Models	and	impact	of	patient	and	
public involvement in studies carried out by the Medical Research 
Council Clinical Trials Unit at University College London: findings 
from ten case studies. Trials.	2016;17(1):1-13.
	13.	 Domecq	JP,	Prutsky	G,	Elraiyah	T,	et	al.	Patient	engagement	in	re-
search: a systematic review. BMC Health Serv Res. 2014;14:1-9.
	14.	 Petit-Zeman	 S,	 Firkins	 L,	 Scadding	 JW.	 The	 James	 Lind	 Alliance:	
tackling research mismatches. Lancet.	2010;376:667-669.
	15.	 Lophatananon	 A,	 Tyndale-Biscoe	 S,	Malcolm	 E,	 et	 al.	 The	 James	
Lind alliance approach to priority setting for prostate cancer re-
search: an integrative methodology based on patient and clinician 
participation. BJU Int. 2011;108:1040-1043.
	16.	 Whitehead	D,	Taket	A,	Smith	P.	Action	research	 in	health	promo-
tion. Health Educ J.	2003;62(1):5-22.
	17.	 Minkler	M,	Wallerstein	N.	Community-Based Participatory Research 
for Health From Process to Outcomes,	2nd	edn.	San	Francisco,	CA:	
Jossey-Bass; 2008.
	18.	 Staniszewska	S,	Brett	J,	Mockford	C,	Barber	R.	The	GRIPP	checklist:	
strengthening the quality of patient and public involvement report-
ing in research. Int J Technol Assess Health Care.	2011;27(4):391-399.
	19.	 Brett	J,	Staniszewska	S,	Mockford	C,	et	al.	Mapping	the	impact	of	
patient and public involvement on health and social care research: a 
systematic review. Health Expect.	2014;17:637-650.
	20.	 Brett	J,	Staniszewska	S,	Mockford	C,	et	al.	A	systematic	review	of	
the impact of patient and public involvement on service users, re-
searchers and communities. Patient.	2014;7(4):387-395.
	21.	 Staley	K.	 ‘Is	 it	worth	doing?’	Measuring	the	impact	of	patient	and	
public involvement in research. Res Involv Engagem.	2015;1:6.
	22.	 Hubbard	G,	Kidd	L,	Donaghy	E.	Involving	people	affected	by	cancer	
in research: a review of literature: Review article. Eur J Cancer Care 
(Engl).	2008;17(3):233-244.
	23.	 Moher	 D,	 Liberati	 A,	 Tetzlaff	 J,	 Altman	 DG.	 Preferred	 reporting	
items	for	systematic	reviews	and	meta-	analyses:	the	PRISMA	state-
ment. BMJ. 2009;339:b2535.
 24. Pluye P. Critical appraisal tools for assessing the methodologi-
cal quality of qualitative, quantitative and mixed methods stud-
ies included in systematic mixed studies reviews. J Eval Clin Pract. 
2013;19:722.
	25.	 Perkins	 P,	 Barclay	 S,	 Booth	 S.	 What	 are	 patients’	 priorities	
for palliative care research? Focus group study. Palliat Med. 
2007;21(3):219-225.
	26.	 Moorcraft	 SY,	 Sangha	 A,	 Peckitt	 C,	 et	 al.	 Does	 cancer	 research	
focus on areas of importance to patients? Ecancermedicalscience. 
2016;10:ed51.
	27.	 Wan	YL,	Beverley-Stevenson	R,	Carlisle	D,	et	al.	Working	together	
to shape the endometrial cancer research agenda: the top ten unan-
swered research questions. Gynecol Oncol.	2016;143(2):287-293.
	28.	 Perkins	P,	Booth	S,	Vowler	SL,	Barclay	S.	What	are	patients’	priori-
ties for palliative care research? A questionnaire study. Palliat Med. 
2008;22(1):7-12.
	29.	 Ashley	L,	Jones	H,	Velikova	G,	Wright	P.	Cancer	patients’	and	clini-
cians’ opinions on the best time in secondary care to approach pa-
tients for recruitment to longitudinal questionnaire- based research. 
Support Care Cancer.	2012;20(12):3365-3372.
 30. Ellis J, Wagland R, Tishelman C, et al. Considerations in develop-
ing and delivering a nonpharmacological intervention for symptom 
management in lung cancer: the views of patients and informal 
caregivers. J Pain Symptom Manage.	2012;44(6):831-842.
	31.	 Fleisher	L,	Ruggieri	DG,	Miller	SM,	et	al.	Application	of	best	practice	
approaches for designing decision support tools: the preparatory 
education about clinical trials (PRE- ACT) study. Patient Educ Couns. 
2014;96(1):63-71.
	32.	 Stephens	RJ,	Whiting	C,	Cowan	KK,	et	al.	Research	priorities	in	me-
sothelioma:	a	James	Lind	Alliance	Priority	Setting	Partnership.	Lung 
Cancer.	2015;89(2):175-180.
	33.	 Taylor	RM,	Solanki	A,	Aslam	N,	Whelan	JS,	Fern	LA.	A	participatory	
study of teenagers and young adults views on access and participa-
tion in cancer research. Eur J Oncol Nurs.	2016;20:156-164.
	34.	 Taylor	RM,	Mohain	J,	Gibson	F,	Solanki	A,	Whelan	J,	Fern	LA.	Novel	
participatory methods of involving patients in research: naming and 
branding	a	longitudinal	cohort	study,	BRIGHTLIGHT.	BMC Med Res 
Methodol. 2015;15(1):1-10.
	35.	 McNair	AGK,	Heywood	N,	Tiernan	J,	et	al.	A	national	patient	and	
public colorectal research agenda: integration of consumer per-
spectives in bowel disease through early consultation. Colorectal 
Dis.	2017;19(1):O75-O85.
	36.	 Rush	 CL,	 Darling	 M,	 Elliott	 MG,	 et	 al.	 Engaging	 Latina	 cancer	
survivors, their caregivers, and community partners in a ran-
domized controlled trial: Nueva Vida intervention. Qual Life Res. 
2015;24(5):1107-1118.
	37.	 Freysteinson	 WM.	 The	 ethical	 community	 consultation	 model	
as preparation for nursing research: a case study. Nurs Ethics. 
2010;17(6):749-758.
	38.	 Islam	KM,	Opoku	 ST,	 Apenteng	BA,	 et	 al.	 Engaging	 patients	 and	
caregivers in patient- centered outcomes research on advanced 
stage lung cancer: insights from patients, caregivers, and providers. 
J Cancer Educ.	2014;29(4):796-801.
 39. Treiman K, McCormack L, Olmsted M, et al. Engaging patient ad-
vocates and other stakeholders to design measures of patient- 
centered communication in cancer care. Patient.	2017;10:93-103.
20  |     PII et al.
	40.	 Wells	KJ,	Quinn	GP,	Meade	CD,	et	al.	Development	of	a	cancer	clin-
ical trials multi- media intervention: clinical trials: are they right for 
you? Patient Educ Couns. 2012;88(2):232-240.
	41.	 McCarrier	KP,	Atkinson	TM,	Debusk	KPA,	Liepa	AM,	Scanlon	M,	Coons	
SJ.	Qualitative	development	and	content	validity	of	the	Non-	small	Cell	
Lung	 Cancer	 Symptom	 Assessment	 Questionnaire	 (NSCLC-	SAQ),	 A	
Patient- reported Outcome Instrument. Clin Ther.	2016;38(4):794-810.
 42. Vargas R, Maxwell AE, Lucas-Wright A, et al. A community partnered- 
participatory	research	approach	to	reduce	cancer	disparities	in	South	
Los Angeles. Prog Community Health Partnersh.	2014;8(4):471-476.
	43.	 Clinton-Mcharg	T,	Paul	C,	 Sanson-Fisher	R,	D’Este	C,	Williamson	
A. Determining research priorities for young people with hae-
matological cancer: a value- weighting approach. Eur J Cancer. 
2010;46(18):3263-3270.
	44.	 Dear	 RF,	 Barratt	AL,	 Crossing	 S,	 Butow	PN,	Hanson	 S,	 Tattersall	
MHN. Consumer input into research: The Australian Cancer Trials 
website. Health Res Policy Syst. 2011;9:1-11.
	45.	 Saunders	 C,	 Crossing	 S.	 Towards	meeting	 the	 research	 needs	 of	
Australian cancer consumers. BMC Res Notes.	2012;5:667.
	46.	 Vivat	B,	Young	T,	Efficace	F,	et	al.	Cross-	cultural	development	of	the	
EORTC	QLQ-	SWB36:	a	stand-	alone	measure	of	spiritual	wellbeing	for	
palliative care patients with cancer. Palliat Med.	2013;27(5):457-469.
	47.	 Dellson	 P,	 Nilbert	 M,	 Bendahl	 PO,	 Malmström	 P,	 Carlsson	 C.	
Towards optimised information about clinical trials; identification 
and validation of key issues in collaboration with cancer patient ad-
vocates. Eur J Cancer Care (Engl). 2011;20(4):445-454.
	48.	 Sperling	CD,	Petersen	G,	Holge-Hazelton	B,	et	al.	Being	young	and	
getting cancer: development of a questionaire reflecting the needs 
and experiences of adolescents and young adults with cancer. J 
Adolesc Young Adult Oncol.	2017;6(1):171-177.
	49.	 van	 Merode	 T,	 Bours	 S,	 van	 Steenkiste	 B,	 et	 al.	 Definition	 von	
Forschungsschwerpunkten bei Patienten mit multiplem Myelom 
oder	M.	Waldenström:	eine	wahrhaft	patientengeführte	Studie.	Z 
Evid Fortbild Qual Gesundhwes.	2016;112:11-18.
	50.	 Chiu	CG,	Mitchell	TL,	Fitch	MI.	From	patient	to	participant:	enhanc-
ing the validity and ethics of cancer research through participatory 
research. J Cancer Educ.	2013;28(2):237-246.
 51. Wright D, Foster C, Amir Z, Elliott J, Wilson R. Critical appraisal 
guidelines for assessing the quality and impact of user involvement 
in research. Health Expect.	2010;13(4):359-368.
	52.	 Green	G.	Power	 to	 the	people:	 to	what	 extent	 has	 public	 involve-
ment in applied health research achieved this? Res Involv Engagem. 
2016;2(1):28.
	53.	 Dawson	S,	Campbell	SM,	Giles	SJ,	Morris	RL,	Cheraghi-Sohi	S.	Black	
and minority ethnic group involvement in health and social care re-
search: a systematic review. Health Expect. 2018;21:3-22.
	54.	 Shippee	 ND,	 Domecq	 Garces	 JP,	 Prutsky	 Lopez	 GJ,	 et	 al.	
Patient and service user engagement in research: a sys-
tematic review and synthesized framework. Health Expect. 
2013;18:1151-1166.
	55.	 Brett	J,	Staniszewska	S,	Mockford	C,	et	al.	The	PIRICOM	Study:	A	
systematic review of the conceptualisation, measurement, impact 
and outcomes of patient and public involvement in health and social 
care research; 2010:1-292.
	56.	 Duffett	L.	Patient	engagement:	what	partnering	with	patient	in	re-
search is all about. Thromb Res.	2017;150:113-120.
	57.	 Mockford	C,	Staniszewska	S,	Griffiths	F,	Herron-Marx	S.	The	 im-
pact	of	patient	and	public	 involvement	on	UK	NHS	health	care:	a	
systematic review. Int J Qual Heal Care. 2012;24(1):28-38.
 58. Boote J, Barber R, Cooper C. Principles and indicators of successful 
consumer	 involvement	 in	NHS	research:	results	of	a	Delphi	study	
and subgroup analysis. Health Policy.	2006;75:280-297.
	59.	 Staniszewska	S,	Brett	J,	Simera	I,	et	al.	GRIPP2	reporting	checklists:	
Tools to improve reporting of patient and public involvement in re-
search. BMJ.	2017;358:j3453.
	60.	 Edelman	 N,	 Barron	 D.	 Evaluation	 of	 public	 involvement	 in	 re-
search: time for a major re- think? J Health Serv Res Policy. 
2016;21(3):209-211.
	61.	 Hepworth	J,	Robertson	ARR,	Jhunjhunwala	A,	Jarvis	GC,	McVittie	
C. Cancer- related psychosocial research: what are the perspectives 
of cancer care centre users on participation? Support Care Cancer. 
2011;19(7):1029-1035.
SUPPORTING INFORMATION
Additional supporting information may be found online in the 
Supporting	Information	section	at	the	end	of	the	article.	
How to cite this article:	Pii	KH,	Schou	LH,	Piil	K,	Jarden	M.	
Current trends in patient and public involvement in cancer 
research: A systematic review. Health Expect. 2019;22:3–20. 
https://doi.org/10.1111/hex.12841
